News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Chiron Corporation (CHIR) Release: PROCLEIX(R) West Nile Virus Assay Receives FDA Approval; New System Further Ensures Safety Of Blood Supply



12/2/2005 12:58:24 PM

EMERYVILLE, Calif.--(BUSINESS WIRE)--Dec. 1, 2005--Chiron Corporation (NASDAQ:CHIR) today announced that the U.S. Food and Drug Administration (FDA) has approved the PROCLEIX(R) West Nile Virus (WNV) Assay to screen whole blood donations for use on the PROCLEIX(R) System. The assay, which was developed in collaboration with Gen-Probe Incorporated, has been used to screen more than 29 million units of blood on an investigational-use-only basis since June of 2003 and intercepted more than 1,500 WNV-positive donations.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES